AdvisorShares Psychedelics ETF PSIL
16.92 USD -0.57 (-3.26%)
As ofNov 20, 2026, 3:16 PM EST
16.92 Day range 17.20
15.64 52-week range 27.02
- YTD
- -1.46%
- 1 year
- -1.91%
5D -1.88 (-9.85%)
- Assets
- $37.92M
- Expense ratio
- 1.28%
- NAV
- 17.60
- Holdings
- 25
- Top 10 weight
- 69.7%
- Asset class
- Equity
- Issuer
- AdvisorShares
- Inception
- Sep 15, 2021
- YTD return
- -1.46%
- 1-year return
- -1.91%
- Volume
- 34.95K
- Avg volume
- 29.59K
- Open
- 17.13
- Previous close
- 17.49
- Day's range
- 16.92 – 17.20
- 52-week range
- 15.64 – 27.02
- 50-day average
- 11.91
- 200-day average
- 11.16
About AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
News
Your note
Sign in to keep a note on PSIL — it syncs with the Stock Master app.
